Search for: "May Chen" Results 261 - 280 of 1,544
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Apr 2022, 5:54 am by Michel Paradis
As former Justice Department attorney Edgar Chen persuasively argued in Just Security in March, closing these loopholes can and should be done immediately to strengthen the country’s ability to respond with all the tools at its disposal. [read post]
8 Apr 2022, 9:06 pm by Taylor Ross
In this instance, Chen contends that “pressure for heightened regulatory procedure functioned as a shield against expanding rights. [read post]
1 Apr 2022, 2:07 pm by Raquel Leslie, Brian Liu
More than 200 of these companies may be subject to delisting under the HFCAA. [read post]
30 Mar 2022, 10:58 am by Kluwer Patent blogger
A new source of conflict at the EPO may be the start of a ‘professional mobility’ project called for by the EPO management. [read post]
They also submitted that any of these substances may be used for the purpose of calculating the time by which an extension of term application must be filed under section 71(2), and it is for the patentee to nominate the substance. [read post]
30 Mar 2022, 12:15 am
Last year, the California legislature enacted AB 663 (Chen) in order to provide California corporations with greater flexibility to hold virtual-only meetings of shareholders. [read post]
22 Mar 2022, 4:38 am by Brian Cordery (Bristows)
Where, as in this case, the patent is for a particular drug, ezetimibe, and the claims in the patent teach that the application in human medicine may be for the use of that drug alone or in combination with another drug, here, simvastatin, a drug in the public domain, can an SPC be granted under Article 3(a) of the Regulation only for a product comprising ezetimibe, a monotherapy, or can an SPC also be granted for any or all of the combination products identified in the claims in the… [read post]
21 Mar 2022, 4:25 am by Miquel Montañá (Clifford Chance)
Although the title of this blog may sound trite to most readers, it may still be of interest to briefly discuss a recent case where this topic was discussed before the Spanish courts in the context of a judicial patent dispute between Erasmus Universiteit Medisch Centrum Rotterdam (“Erasmus) and its licensee, on the one hand, and two companies named Vitro S.A. [read post]
12 Mar 2022, 2:14 am by Dr. Narayan Sircar (Hoffmann Eitle)
If, in an action for a declaration of invalidity of a patent brought by several plaintiffs, the proceedings against one of the plaintiffs are interrupted pursuant to Section 240 of the Code of Civil Procedure (CCP), a partial judgment may be given against the other plaintiffs. [read post]
In particular, the author notes that dictionary definitions are reflective of common usage, and none of the cited dictionary definitions for “inventor” recognise that an inventor may be a non-human agent that invents. [read post]
4 Mar 2022, 5:01 am by Raquel Leslie, Brian Liu
Prosecutors concluded that their evidence against Gang Chen, a U.S. citizen, no longer met the burden of proof at trial. [read post]